Search For "covid 19 vaccine"
USAID's CoVLEx Initiative Brings Private Sector Learnings to the Global So
Updated : 4 years ago IST
New Delhi [India], March 10 (ANI/NewsVoir): The U.S. Agency for International Development (USAID) and Population Services International (PSI), hosted a virtual discussion through the City-to-City COVID-19 Vaccine Learning Exchange (CoVLEx) initiative. Representatives from cities and countrie
Read More
More than 16.24 cr unutilized vaccine doses still available with States, U
Updated : 4 years ago IST
New Delhi [India], March 10 (ANI): More than 16.24 crore balance and unutilized COVID-19 vaccine doses are still available with the States and Union Territories to be administered, the Ministry of Health and Family Welfare informed on Thursday.
Read More
Over 180.61 crore unutilized COVID-19 vaccine doses available with states,
Updated : 4 years ago IST
New Delhi [India], March 10 (ANI): The Centre on Thursday said that more than 180.61 crore unutilized COVID-19 vaccine doses are still available with the states and Union Territories.
Read More
AIIMS Delhi to start clinical trial of intranasal COVID-19 vaccine from Fr
Updated : 4 years ago IST
New Delhi [India], March 9 (ANI): All India Institute of Medical Sciences (AIIMS) Delhi will start the clinical trials of Bharat Biotech's intranasal booster dose against COVID-19 from Friday, said sources.
Read More
DCGI grants emergency use authorisation to SII's COVID-19 vaccine Covovax
Updated : 4 years ago IST
New Delhi [India], March 9 (ANI): The Drugs Controller General of India (DCGI) has granted Emergency Use Authorisation (EUA) to Serum Institute of India's (SII) COVID-19 vaccine Covovax for adults and for children above the age of 12 years.
Read More
Biological E seeks EUA for COVID vaccine Corbevax for children in 5-12 age
Updated : 4 years ago IST
New Delhi [India], March 9 (ANI): Hyderabad-based pharmaceutical company Biological E has applied for Emergency Use Authorisation (EUA) for its COVID-19 vaccine Corbevax for the 5-12 year age group, official sources said on Wednesday.
Read More
Chinese health commission document reveals country's Covid-19 vaccines cau
Updated : 4 years ago IST
Beijing [China], March 8 (ANI): A recent internal document from the Chinese National Health Commission (NHC) showed that the (Chinese) COVID-19 vaccines had caused leukaemia, local media reported.
Read More
COVID-19: FDA gives clearance to Covaxin for clinical trials in adults in
Updated : 4 years ago IST
New Delhi [India], March 7 (ANI): Bharat Biotech's COVID-19 vaccine Covaxin has been given clearance for clinical trials in adults by the US Food and Drug Administration (FDA).
Read More
China's 'COVID-19 diplomacy' merely facade to sell vaccines: Report
Updated : 4 years ago IST
Beijing [China], March 5 (ANI): The impression that China has tried to give since the COVID-19 vaccines became available that the country is extending a helping hand by providing vaccines to several countries is a facade with the aim to sell vaccines to affected countries, a report said on T
Read More
SEC recommends granting emergency use authorisation to Serum Institute of
Updated : 4 years ago IST
New Delhi [India], March 4 (ANI): The Subject Expert Committee (SEC) has recommended granting emergency use authorisation (EUA) to Serum India of India's COVID-19 vaccine Covovax for the age group 12-17, said the official sources.
Read More
Decision on mixing, matching of COVID-19 vaccine booster dose will be base
Updated : 4 years ago IST
New Delhi [India], March 3 (ANI): The Union Health Ministry on Thursday said that any decision on the mixing and matching of the booster dose of COVID-19 vaccines will be taken based on science.
Read More
COVID-19 vaccination: India rapidly marching towards achieving 100 pc firs
Updated : 4 years ago IST
New Delhi [India], March 3 (ANI): Union Minister of Health and Family Welfare Mansukh Mandaviya on Thursday said that the country is "marching" towards achieving 100 per cent inoculation of the first dose of the COVID-19 vaccine of the adult population.
Read More